Amantadine
CHEBI:CHEBI_2618
Definition
A member of the class of adamantanes that is used as an antiviral and antiparkinson drug.
Chemical Information
- Molecular Formula
- C10H17N
- Molecular Mass
- 151.24870
- Charge
- 0
- SMILES
- NC12CC3CC(CC(C3)C1)C2
- InChI
- InChI=1S/C10H17N/c11-10-4-7-1-8(5-10)3-9(2-7)6-10/h7-9H,1-6,11H2
- InChIKey
- DKNWSYNQZKUICI-UHFFFAOYSA-N
Alternative Names
- 1-adamantanamine
- 1-adamantylamine
- 1-aminoadamantane
- adamantan-1-ylamine
- amantadina
- amantadine
- Amantadine
- amantadinum
- Amantidine
- Aminoadamantane
- tricyclo[3.3.1.1(3,7)]decan-1-amine
- tricyclo[3.3.1.1(3,7)]decan-1-ylamine
- tricyclo[3.3.1.1(3,7)]decane-1-amine
- Viregyt
- Virosol
Treatment Applications
-
Nipah virus encephalitisView Disease →
DOID:0050192
-
obsolete tertiary syphilitic encephalitisView Disease →
DOID:0050492
-
Japanese encephalitisView Disease →
DOID:10844
-
postencephalitic Parkinson diseaseView Disease →
DOID:14332
-
borna diseaseView Disease →
DOID:5154
Drug Classification
-
primary aliphatic amineView Class →
CHEBI:17062
-
adamantanesView Class →
CHEBI:51339
-
t154483
-
t154612
-
t154859
-
t154877
-
t155288
-
t155297
-
t155667
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
- core#notation
- CHEBI:2618
- DRON_00010000
- 620
- oboInOwl#hasDbXref
- Wikipedia:Amantadine
Additional References
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- package_description
- 25 kg in 1 BOTTLE (10695-014-70)
- package_ndc
- 70482-170-61
- listing_expiration_date
- 20241231
- route
- ORAL
- marketing_start_date
- 20201020
- spl_id
- f71aa8a6-9093-49ea-b9f2-23a69722dcd4
- product_type
- BULK INGREDIENT
- marketing_category
- BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
- dosage_form
- CAPSULE, COATED PELLETS
- labeler_name
- Spectrum Chemicals and Laboratory Products
- application_number
- ANDA070589
- product_ndc
- 11014-0245
- rxcui
- 2044726
- manufacturer_name
- APNAR PHARMA LP
- package_marketing_start_date
- 19930628
- unii
- BF4C9Z1J53
- core#notation
- CHEBI:2618
- active_ingredient_strength
- 129 mg/1
- active_ingredient_name
- AMANTADINE SULFATE
- spl_set_id
- 5232b933-1df9-43b4-8ac2-61bfa4855e68
- pharm_class_epc
- Influenza A M2 Protein Inhibitor [EPC]
- pharm_class
- M2 Protein Inhibitors [MoA]
- pharm_class_moa
- M2 Protein Inhibitors [MoA]
- nui
- N0000175542
- upc
- 0308321015001
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- oboInOwl#hasOBONamespace
- chebi_ontology
- DRON_00010000
- 620
- generic_name
- Amantadine Sulphate
- brand_name
- Amantadine HCl
- brand_name_base
- Amantadine HCl
- oboInOwl#hasDbXref
- Wikipedia:Amantadine
- oboInOwl#id
- CHEBI:2618
- RO_0000087
- http://purl.obolibrary.org/obo/CHEBI_48560
- oboInOwl#inSubset
- http://purl.obolibrary.org/obo/chebi#3_STAR
- chebi#has_parent_hydride
- http://purl.obolibrary.org/obo/CHEBI_40519
- chebi#is_conjugate_base_of
- http://purl.obolibrary.org/obo/CHEBI_48320
- has_treatment
- http://purl.obolibrary.org/obo/DOID_8544
- rdf-schema#range
- https://w3id.org/def/predibionto#has_drug_111364
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_side_effect11699
- chebi#is_conjugate_acid_of
- http://purl.obolibrary.org/obo/CHEBI_48320
- owl#annotatedSource
- t155537
- owl#someValuesFrom
- t3278172